What Happened?
Shares of lab services company Charles River Laboratories (NYSE: CRL) jumped 5.7% in the afternoon session after the company outlined long-term financial targets through 2030 and raised its 2026 earnings outlook at its Investor Day.
The company projected 5% to 7% compound annual organic revenue growth through 2030. Organic revenue growth excludes the effects of acquisitions, divestitures, and currency changes. It also targeted an operating margin near 24%. Charles River expects its Create the Future efficiency program to produce more than $300 million in cumulative savings through 2030. At the event, the company also presented its Pathway to Purpose strategy. The plan aims to modernize operations, strengthen its scientific portfolio, improve the client experience, and support profitable long-term growth.
Is now the time to buy Charles River Laboratories? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Charles River Laboratories’s shares are quite volatile and have had 19 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 7 days ago when the stock gained 3.6% on the news that the company announced the launch of rapid cell banking programs designed to accelerate release timelines. According to a company press release, the newly launched programs offer a 40% reduction in cell bank production time compared to the 20-week industry standard. Under the comprehensive solution, rapid cell bank and release packages are paired with Next-Generation Sequencing characterization. Charles River Laboratories stated that this solution is designed to improve product quality, safety, and regulatory readiness while reducing overall development timelines.
Charles River Laboratories is up 45.9% since the beginning of the year, and at $295.38 per share, it is trading close to its 52-week high of $298.58 from August 2026. Despite the year-to-date gain, investors who bought $1,000 worth of Charles River Laboratories’s shares 5 years ago would now be looking at only $644.50.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
